HeartFlow’s AI-enabled plaque quantification technology has been upgraded to a new I CPT category code by the American Medical Association.

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

Individuals with primary biliary cholangitis and diabetes may experience worse outcomes, such as progression to end-stage liver disease.

Continuous moderate-level maternal psychological distress throughout pregnancy is associated with a heightened risk for epilepsy among offspring.

Diabetic hypoglycemia occurs when a person's blood sugar level falls too low. Symptoms can include: shakiness, confusion or ...

A large study suggests that, across the most populous US states, few physicians are disciplined for spreading medical ...

Detailed results were announced from the phase 3 SUMMIT trial evaluating the use of tirzepatide in adults with HFpEF and obesity.

Authors say technology may enable noninvasive screening. HealthDay News — Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and ...

Relaxed glycemic control targets were associated with an increased risk for skin, bone, and soft tissue infections among older adults with type 2 diabetes. Older adults with type 2 diabetes and ...

The increased risks for arterial thrombotic events (ATE), venous thromboembolism (VTE), and all-cause mortality known to be found among patients with systemic lupus erythematosus (SLE) were validated ...

GLP-1RA medications in preadolescents and adolescents were concentrated among those with diabetes, obesity, mood disorders, and anxiety.

Individuals with lower health literacy may have more advanced metabolic dysfunction-associated steatotic liver disease. Lower health literacy is associated with greater disease severity in metabolic ...